ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 189 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $28,990,000 | +856.5% | 311,918 | +512.7% | 0.01% | +400.0% |
Q3 2021 | $3,031,000 | +335.5% | 50,905 | +398.7% | 0.00% | – |
Q2 2021 | $696,000 | -89.7% | 10,208 | -89.6% | 0.00% | -100.0% |
Q1 2021 | $6,782,000 | +20.6% | 97,727 | +33.5% | 0.00% | +33.3% |
Q4 2020 | $5,625,000 | -27.8% | 73,215 | -29.7% | 0.00% | -25.0% |
Q3 2020 | $7,795,000 | +69.3% | 104,213 | +42.6% | 0.00% | 0.0% |
Q2 2020 | $4,605,000 | +39.6% | 73,099 | -6.9% | 0.00% | +33.3% |
Q1 2020 | $3,298,000 | -35.6% | 78,521 | -30.4% | 0.00% | 0.0% |
Q4 2019 | $5,121,000 | +124.1% | 112,756 | +125.8% | 0.00% | +200.0% |
Q3 2019 | $2,285,000 | -37.7% | 49,928 | -20.1% | 0.00% | -50.0% |
Q2 2019 | $3,665,000 | +185.7% | 62,508 | +118.2% | 0.00% | +100.0% |
Q1 2019 | $1,283,000 | +1904.7% | 28,645 | +1649.8% | 0.00% | – |
Q4 2018 | $64,000 | -95.8% | 1,637 | -95.1% | 0.00% | -100.0% |
Q3 2018 | $1,533,000 | -34.7% | 33,319 | -38.1% | 0.00% | -50.0% |
Q2 2018 | $2,346,000 | -72.1% | 53,823 | -74.7% | 0.00% | -71.4% |
Q1 2018 | $8,410,000 | +446.1% | 212,922 | +369.6% | 0.01% | +250.0% |
Q4 2017 | $1,540,000 | +63.7% | 45,345 | +22.7% | 0.00% | +100.0% |
Q3 2017 | $941,000 | +266.1% | 36,965 | +142.0% | 0.00% | – |
Q2 2017 | $257,000 | – | 15,277 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |